Alven

Activity from announced rounds

All recorded activity

Alven is an investment firm whose own news covers Archy’s Series C and which Attention identifies as a returning investor.

Recorded funding activity

Archy combines dental-practice operations and clinical software with AI tools for routine administrative work. Attention develops agents for revenue-team workflows. The recorded history also includes Generare, which produces molecular data for drug development. These company-level events connect Alven’s attribution across distinct business applications.

Sources
Rounds participated in
7
Confirmed lead rounds
0
6 roles undisclosed
New companies
7
First participation on record · 0 follow-on
Funding in participating rounds
$234.2M
7 disclosed · full round size, not this investor’s share

By stage

Series A3
Series B2
Series C+2

By primary sector

Fintech2
AI1
Biotech1
Enterprise software1
Foodtech1
1 more
Healthtech1

By country

France5
United States2

Rounds

7 in all activity
Archy

Cloud software combines dental practice operations and clinical tools with AI agents for routine administrative work.

$50MSeries C
Participant
Attention

AI platform automates revenue team workflows with action-based AI agents

$30MSeries B
Role not disclosed
Generare

Generates molecular data for drug development

€20MSeries A
Role not disclosed
Kestra

Provides open-source orchestration platform unifying data, AI, infrastructure and business workflows

$25MSeries A
Role not disclosed
Cryptio

Provides accounting and reporting software for digital asset businesses

$45MSeries B
Role not disclosed
Verley

Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers

€32MSeries A
Role not disclosed
Stoïk

Stoïk combines cyber insurance with active cyber-risk prevention.

€20MSeries C
Role not disclosed